v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 4,039,298 $ 8,781,059
Advances and deposits on clinical programs and other current assets 1,798,851 1,942,685
Total current assets 5,838,149 10,723,744
Property and equipment (at cost, less accumulated depreciation and amortization) 393,696 529,936
Other assets:    
Restricted cash 5,039,468
Operating lease right-of-use assets, net 687,365 984,436
Deposits and other assets 50,000 50,000
Total other assets 5,776,833 1,034,436
Total assets 12,008,678 12,288,116
Current liabilities:    
Accounts payable - trade 1,276,747 1,392,829
Other accrued liabilities 1,137,346 2,824,646
Note payable - Note A-1 - current portion 1,344,728
Operating lease liability - current portion 444,982 406,354
Derivative liability associated with redemption feature of Note A-1 34,809
Total current liabilities 4,238,612 4,623,829
Note payable - Note B 4,884,625
Operating lease liability - non-current portion 263,115 602,411
Total liabilities 9,386,352 5,226,240
Commitments and contingencies
Stockholders’ equity:    
Common stock - $0.01 par value (350,000,000 shares authorized; 6,210,958 and 3,419,652 shares issued at September 30, 2026 and December 31, 2025, respectively; and 6,210,956 and 3,419,650 shares outstanding at September 30, 2026 and December 31, 2025, respectively) 62,110 34,197
 Additional paid-in capital 431,373,320 428,410,939
 Accumulated deficit (432,111,495) (421,298,072)
Total stockholders’ equity before treasury stock 2,707,514 7,147,064
Treasury stock, at cost (2 shares at September 30, 2026 and December 31, 2025) (85,188) (85,188)
Total stockholders’ equity 2,622,326 7,061,876
Total liabilities and stockholders’ equity 12,008,678 12,288,116
Series A Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock, value 3
Additional paid-in capital - preferred stock 2,251,918
Series B Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock, value 1
Additional paid-in capital - preferred stock $ 1,131,657